Drugs / Total glucosides of paeony
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT04618575 | Mar 2021 → Nov 2022 | autoimmune disease, hepatitis, primary biliary cholangitis | West China Hospital | Unknown | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT03608917 | Apr 2018 → Apr 2019 | vitiligo | xjpfW | Completed | No outcome recorded |
| — | NCT02191020 | Feb → Oct 2013 | psoriasis | Xijing Hospital | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT04066803 Background | Aug 2018 → Jul 2020 | rheumatoid arthritis | Sun Yat-sen University | Unknown | No outcome recorded |
| — | NCT05973097 Comparator | Jul 2023 → Dec 2028 expected | lichen planus, oral | Peking University Third Hospital | Recruiting | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Total glucosides of paeony | “including Leflunomide，Hydroxychloroquine,Sulfasalazine,Azathioprine,Tripterygium glycosides and Total glucosides of paeony” NCT04066803 ↗ |
| Known as | TGP | “Total Glucosides of Paeony(TGP) as a traditional Chinese medicine” NCT03608917 ↗ |
| Action | Inhibit | “mainly acts on the upstream of the immune response - inhibiting the presentation of antigens.” NCT03608917 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Total Glucosides of Paeony(TGP) as a traditional Chinese medicine” NCT03608917 ↗ |
| Route | Oral | “0.6g，oral，b.i.d.During the other weeks，0.6g，oral，t.i.d” NCT02191020 ↗ |